Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors

Abstract

Awaiting results of the randomized CARDIA trial, TTE should in high-volume centers be considered the preferred approach due to favorable oncologic outcomes.